<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen D</submitter><funding>Catalyst: Seeding Dumont d'Urville NZ-France Science &amp;amp; Technology Support Programme</funding><funding>Wellcome Trust</funding><pagination>5913</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9501421</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(18)</volume><pubmed_abstract>New therapeutic options to combat the growing incidence of antimicrobial resistance are urgently needed. A 2015 publication reported the isolation and biological evaluation of two diketopiperazine natural products, cyclo(l-Trp-l-Arg) (CDP 2) and cyclo(d-Trp-d-Arg) (CDP 3), from an &lt;i>Achromobacter&lt;/i> sp. bacterium, finding that the latter metabolite in particular exhibited strong antibacterial activity towards a range of wound-related microorganisms and could synergize the action of ampicillin. Intrigued by these biological activities and noting inconsistencies in the structural characterization of the natural products, we synthesized the four diastereomers of cyclo(Trp-Arg) and evaluated them for antimicrobial and antibiotic enhancement properties. The detailed comparison of spectroscopi</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Total Synthesis of the Four Stereoisomers of Cyclo(l-Trp-l-Arg) Raises Uncertainty of the Structures of the Natural Products and Invalidates Their Promising Antimicrobial Activities.</pubmed_title><pmcid>PMC9501421</pmcid><funding_grant_id>19-UOA-057-DDU</funding_grant_id><pubmed_authors>Cadelis MM</pubmed_authors><pubmed_authors>Douafer H</pubmed_authors><pubmed_authors>Brunel JM</pubmed_authors><pubmed_authors>Park DJ</pubmed_authors><pubmed_authors>Bourguet-Kondracki ML</pubmed_authors><pubmed_authors>Copp BR</pubmed_authors><pubmed_authors>Chen D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Total Synthesis of the Four Stereoisomers of Cyclo(l-Trp-l-Arg) Raises Uncertainty of the Structures of the Natural Products and Invalidates Their Promising Antimicrobial Activities.</name><description>New therapeutic options to combat the growing incidence of antimicrobial resistance are urgently needed. A 2015 publication reported the isolation and biological evaluation of two diketopiperazine natural products, cyclo(l-Trp-l-Arg) (CDP 2) and cyclo(d-Trp-d-Arg) (CDP 3), from an &lt;i>Achromobacter&lt;/i> sp. bacterium, finding that the latter metabolite in particular exhibited strong antibacterial activity towards a range of wound-related microorganisms and could synergize the action of ampicillin. Intrigued by these biological activities and noting inconsistencies in the structural characterization of the natural products, we synthesized the four diastereomers of cyclo(Trp-Arg) and evaluated them for antimicrobial and antibiotic enhancement properties. The detailed comparison of spectroscopi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-05-18T12:51:01.425Z</modification><creation>2025-04-06T00:13:58.731Z</creation></dates><accession>S-EPMC9501421</accession><cross_references><pubmed>36144649</pubmed><doi>10.3390/molecules27185913</doi></cross_references></HashMap>